A Study To Evaluate the Relative Bioavailability, Food Effect, and Dose Proportionality of a Granule Formulation of Vanzacaftor/Tezacaftor/Deutivacaftor(VNZ/TEZ/D-IVA)
Clinical trial NCT06299709 · COMPLETED
Trial details
- NCT number
- NCT06299709
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-13
- Primary completion
- 2024-05-23
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.